/Lists

Healthtech Series C Investors & VC Firms

564 firms in this list, with a median first check of $1M. 141 of them lead rounds. Generated from verified public data and updated continuously.

Heliad AG
Frankfurt am MainPre-Seed–Late Stage$5.4M – $16.2M
14 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
19 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Wittington Ventures
TorontoSeed–Growth
12 people
359 Capital
New York CitySeed–Series C
10 people
Velvet Sea Ventures
West Palm BeachSeed–Growth
10 people
LifeSci Venture Partners
New YorkSeries A–Series C
6 people
Gilead Sciences
Foster CitySeries B–Late Stage
19 people
Quadrille Capital
ParisSeed–Late Stage
15 people
Bridge Bank
San FranciscoSeed–Late Stage
16 people
Channel 4 Ventures
LondonSeed–Late Stage$2.6M – $13M
5 people
OWW Capital Partners Pte. Ltd.
SingaporeSeed–Late Stage$500K – $10M
9 people
AMR Action Fund
BostonSeed–Growth
13 people
Excel Venture Management
BostonSeries A–Late Stage$1M – $5M
7 people
Third Eye Capital
TorontoSeed–Late Stage
21 people
Peak State Ventures
New YorkPre-Seed–Late Stage$100K – $15M
1 person
APERTURE Venture Partners
New YorkSeed–Series C$1M – $5M
4 people
Fujitsu Ventures
TokyoSeed–Growth
14 people
Stateless Ventures
San FranciscoPre-Seed–Late Stage
8 people
Rho Capital Partners
New YorkSeed–Growth
9 people
Champel Capital
JerusalemSeed–Late Stage
14 people
Seroba Life Sciences
DublinSeed–Growth$540K – $7.6M
13 people
Puhua Capital
HangzhouPre-Seed–Growth
AbCellera
VancouverSeries B–Late Stage
26 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.